11:33 AM
Dec 05, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Colorectal cancer

Cell culture and mouse studies suggest promoting CTNNB1 citrullination or PAD2 expression could help treat colorectal cancer. Screening of approved drugs in HEK cell-based assays of CTNNB1 signaling and cell line-based citrullination and binding assays in human colorectal cancer on the top hit identified Alinia nitazoxanide and...

Read the full 222 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >